This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jw Pharmaceutical Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Yong-Sil Lee
Introduction
Yong-Sil Lee is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. His work focuses on innovative solutions to combat serious diseases, including cancer.
Latest Patents
Yong-Sil Lee holds a patent for a "Compound of a reverse-turn mimetic and a production method and use therefor." This invention relates to novel compounds of reverse-turn mimetics, which have pyrazino-triazinone as a basic framework. The method of preparing these compounds and their use in treating diseases such as cancer, particularly acute myeloid leukemia, showcases his commitment to advancing medical science.
Career Highlights
Yong-Sil Lee is associated with Jw Pharmaceutical Corporation, where he continues to contribute to research and development efforts. His work has been instrumental in creating innovative therapeutic options that address critical health challenges.
Collaborations
He has collaborated with notable colleagues, including Jae-Uk Chung and Mi-Jung Kim, to further enhance the impact of his research and inventions.
Conclusion
Yong-Sil Lee's innovative work in developing compounds for cancer treatment exemplifies the vital role of inventors in advancing healthcare solutions. His contributions are paving the way for new therapeutic strategies that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile